Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors
David Colquhoun(University College London)
Cited by 901
Related Papers
“Stress” and coronary heart disease: psychosocial risk factors
|The Medical Journal of Australia|2003|561
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
|Journal of the American College of Cardiology|2014|527